latest news releases from the newsroom
Elite Pharmaceuticals, Inc.
Elite Pharmaceuticals Elects Wall Street Veteran Jerry Treppel to the Board of Directors
NORTHVALE, N.J., Nov. 3, 2008 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the "Company") (AMEX:ELI) today announced that on October 28th , 2008, the Company increased the size of its board of directors (the "Board") from five (5) members to six (6) members and elected Jerry I. Treppel as the additional director.
Klayman & Toskes P.A.
Notice From the Securities Law Firm of Klayman & Toskes to All UBS Customers Who Purchased Lehman Brothers Structured Products and Notes
NEW YORK, Nov. 3, 2008 (GLOBE NEWSWIRE) -- The Securities Law Firm of Klayman & Toskes, P.A., www.nasd-law.com, announced today that it is investigating claims on behalf of investors who purchased Lehman Brothers structured products including Lehman Brothers Principal Protected Notes ("Lehman Principal Protected Notes") from UBS (NYSE:UBS). Also referred to as guaranteed linked notes, Lehman Principal Protected Notes were "structured products" that combined fixed income investments with derivatives. What resulted was a product that supposedly provided the protection of fixed income, with the upside of the stock market.